Skip to content
Home

Category: induced pluripotent stem cells

Study by Mayo clinic shows stem cells repair mouse heart

July 20, 2009 by srrpenna

ROCHESTER, Minn. -- In a proof-of-concept study, Mayo Clinic investigators have demonstrated that induced pluripotent stem (iPS) cells can be used to treat heart disease. iPS cells are stem cells converted from adult cells. In this study, the researchers reprogrammed ordinary fibroblasts, cells that contribute to scars such as those resulting from a heart attack, converting them into stem cells that fix heart damage caused by infarction. The findings appear in the current online issue of the journal Circulation.

Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway

July 8, 2009 by srrpenna

LA JOLLA, Calif., and BARCELONA, July 8 /PRNewswire/ -- Fate Therapeutics, Inc. announced today the presentation of data from its research on small molecule modulators of the Wnt pathway for osteo-regeneration at the 7th Annual Meeting of the International Society for Stem Cell Research (ISSCR) in Barcelona, Spain. In its findings, the Company demonstrated that selected Wnt activators induce the differentiation of mesenchymal stem cells to mature, bone-forming osteoblasts. The study highlights the potential for using small molecule Wnt activators as osteogenic agents.

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

July 8, 2009 by srrpenna

Findings to be Presented at the International Society of Stem Cell Research (ISSCR) Annual Meeting Demonstrate that Any Stored Blood Sample is a Candidate for iPS Cell Reprogramming

AdaptiveThemes